1. Trang chủ
  2. » Y Tế - Sức Khỏe

Clinics in chest medicine 2006

224 686 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 224
Dung lượng 6,49 MB
File đính kèm Clinics in chest medicine 2006.rar (5 MB)

Nội dung

Một cuốn sách hay về các loại bệnh lồng ngực bao gồm các chương Pathology of the Pleura Pleural Fibrosis Imaging of Pleural Disease Pleural Ultrasonography Pleural Manometry Discriminating Between Transudates and Exudates The Approach to the Patient with a Parapneumonic Effusion The Spectrum of Pleural Effusions After Coronary Artery Bypass Grafting Surgery

Ngày đăng: 22/07/2018, 15:13

Nguồn tham khảo

Tài liệu tham khảo Loại Chi tiết
[30] Gordon GJ, Rockwell GN, Jensen RV, et al. Iden- tification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. Am J Pathol 2005;166:1827 – 40 Sách, tạp chí
Tiêu đề: Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling
Tác giả: Gordon GJ, Rockwell GN, Jensen RV
Nhà XB: Am J Pathol
Năm: 2005
[34] Fleury-Feith J, Pilatte Y, Jaurand MC. Cells in the pleural cavity. In: Light RW, Lee YC, editors. Text- book of pleural diseases. London 7 Arnold; 2003.p. 17 – 34 Sách, tạp chí
Tiêu đề: Textbook of pleural diseases
Tác giả: Fleury-Feith J, Pilatte Y, Jaurand MC
Nhà XB: Arnold
Năm: 2003
[37] Cury PM, Butcher DN, Corrin B, Nicholson AG. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyper- plasia and reactive pleural fibrosis. J Pathol 1999;189:251 – 7 Sách, tạp chí
Tiêu đề: The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis
Tác giả: Cury PM, Butcher DN, Corrin B, Nicholson AG
Nhà XB: J Pathol
Năm: 1999
[40] Hulks G, Thomas JS, Waclawski E. Malignant pleural mesothelioma in western Glasgow 1980 – 6. Thorax 1989;44:496 – 500 Sách, tạp chí
Tiêu đề: Malignant pleural mesothelioma in western Glasgow 1980 – 6
Tác giả: Hulks G, Thomas JS, Waclawski E
Nhà XB: Thorax
Năm: 1989
[43] Wang NS. Pleural mesothelioma: an approach to diagnostic problems. Respirology 1996;1:259 – 71 Sách, tạp chí
Tiêu đề: Pleural mesothelioma: an approach to diagnostic problems
Tác giả: Wang NS
Nhà XB: Respirology
Năm: 1996
[52] Plas E, Riedl CR, Pfluger H. Malignant mesothe- lioma of the tunica vaginalis testis: review of the literature and assessment of prognostic parameters.Cancer 1998;83:2437 – 46 Sách, tạp chí
Tiêu đề: Malignant mesothelioma of the tunica vaginalis testis: review of the literature and assessment of prognostic parameters
Tác giả: Plas E, Riedl CR, Pfluger H
Nhà XB: Cancer
Năm: 1998
[60] Ceresoli GL, Locati LD, Ferreri AJ, et al. Therapeutic outcome according to histologic subtype in 121 pa- tients with malignant pleural mesothelioma. Lung Cancer 2001;34:279 – 87.west & lee350 Sách, tạp chí
Tiêu đề: Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma
Tác giả: Ceresoli GL, Locati LD, Ferreri AJ, et al
Nhà XB: Lung Cancer
Năm: 2001
[1] Lanphear BP, Buncher CR. Latent period for malig- nant mesothelioma of occupational origin. J Occup Med 1992;34:718 – 21 Khác
[29] Singhal S, Wiewrodt R, Malden LD, et al. Gene ex- pression profiling of malignant mesothelioma. Clin Cancer Res 2003;9:3080 – 97 Khác
[31] Hegmans JP, Bard MP, Hemmes A, et al. Proteomic analysis of exosomes secreted by human mesothe- lioma cells. Am J Pathol 2004;164:1807 – 15 Khác
[32] Lopez-Rios F, Illei PB, Rusch V, Ladanyi M. Evi- dence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in com- mon laboratory plasmids. Lancet 2004;364:1157 – 66 Khác
[33] Manfredi JJ, Dong J, Liu WJ, et al. Evidence against a role for SV40 in human mesothelioma. Cancer Res 2005;65:2602 – 9 Khác
[35] Whitaker D, Henderson DW, Shilkin KB. The concept of mesothelioma in situ: implications for diagnosis and histogenesis. Semin Diagn Pathol 1992;9:151 – 61 Khác
[36] Henderson DW, Shilkin KB, Whitaker D. Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review. Am J Clin Pathol 1998;110:397 – 404 Khác
[38] Corson JM. Pathology of diffuse malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 1997;9:347 – 55 Khác
[39] Sugarbaker DJ, Garcia JP, Richards WG, et al. Extra- pleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 con- secutive patients. Ann Surg 1996;224:288 – 94 Khác
[41] King JA, Tucker JA, Wong SW. Mesothelioma: a study of 22 gases. South Med J 1997;90:199 – 205 Khác
[42] Baldini EH, Recht A, Strauss GM, et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 1997;63:334 – 8 Khác
[44] Antman K, Shemin R, Ryan L, et al. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute andBrigham and Women’s Hospital experience over two decades, 1965 – 1985. J Clin Oncol 1988;6:147 – 53 Khác
[46] Chahinian AP, Pajak TF, Holland JF, et al. Diffuse malignant mesothelioma: prospective evaluation of 69 patients. Ann Intern Med 1982;96(6 Pt 1):746 – 55 Khác

TỪ KHÓA LIÊN QUAN